GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lumos Pharma Inc (FRA:4NX1) » Definitions » 6-1 Month Momentum %

Lumos Pharma (FRA:4NX1) 6-1 Month Momentum % : -43.01% (As of May. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Lumos Pharma 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-21), Lumos Pharma's 6-1 Month Momentum % is -43.01%.

The industry rank for Lumos Pharma's 6-1 Month Momentum % or its related term are showing as below:

FRA:4NX1's 6-1 Month Momentum % is ranked worse than
60.21% of 1528 companies
in the Biotechnology industry
Industry Median: -5.545 vs FRA:4NX1: -43.01

Competitive Comparison of Lumos Pharma's 6-1 Month Momentum %

For the Biotechnology subindustry, Lumos Pharma's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumos Pharma's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lumos Pharma's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Lumos Pharma's 6-1 Month Momentum % falls into.



Lumos Pharma  (FRA:4NX1) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Pharma  (FRA:4NX1) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Lumos Pharma 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Lumos Pharma's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumos Pharma (FRA:4NX1) Business Description

Traded in Other Exchanges
Address
4200 Marathon Boulevard, Suite 200, Austin, TX, USA, 78756
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States.

Lumos Pharma (FRA:4NX1) Headlines

No Headlines